CPG
ACHV icon

Cornerstone Planning Group’s Achieve Life Sciences ACHV Stock Holding History

Cornerstone Planning Group’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-100
Closed -$436 – 1819
2025
Q4 		$436 Buy
100
+87
+669% +$379 ﹤0.01% 1534
2025
Q3 		$4.68K Sell
13
-87
-87% -$239 ﹤0.01% 969
2025
Q2 		$262 Hold
100
– – ﹤0.01% 1440
2025
Q1 		$243 Hold
100
– – ﹤0.01% 1449
2024
Q4 		$311 Hold
100
– – ﹤0.01% 1277
2024
Q3 		$472 Hold
100
– – ﹤0.01% 1099
2024
Q2 		$447 Hold
100
– – ﹤0.01% 1092
2024
Q1 		$474 Hold
100
– – ﹤0.01% 948
2023
Q4 		$412 Hold
100
– – ﹤0.01% 796
2023
Q3 		$430 Buy
+100
New +$504 ﹤0.01% 914

Other funds holding ACHV

Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cornerstone Planning Group's ACHV Position: Q1 2026 in Review

Cornerstone Planning Group sold out of Achieve Life Sciences (ACHV) in Q1 2026, closing a stake of 100 shares — an estimated $436 sold.

Cornerstone Planning Group first reported a position in ACHV in Q3 2023 and held it in 10 quarters. The position peaked at $4.68K in Q3 2025. 81 funds tracked by Wall St. Rank hold ACHV as of Q1 2026.

  • Cornerstone Planning Group reported no remaining Achieve Life Sciences position as of Q1 2026 after selling out during the quarter.
  • Cornerstone Planning Group sold 100 Achieve Life Sciences shares in Q1 2026, an estimated $436.
  • Cornerstone Planning Group first reported a position in Achieve Life Sciences in Q3 2023 and held it in 10 quarters.
  • Cornerstone Planning Group's Achieve Life Sciences position peaked at $4.68K in Q3 2025.
  • 81 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q1 2026.

Based on Cornerstone Planning Group's 13F filing for Q1 2026, filed 6 May 2026.